Valley National Bancorp Reports Strong 2025 Earnings, Boosts Capital, and Authorizes New Share Repurchase
Summary
Valley National Bancorp reported a significant increase in net income and EPS for 2025, alongside improved capital and liquidity ratios, and authorized a new 25 million share repurchase program.
Key Events
-
Record 2025 Financial Performance
Net income increased to $598.0 million ($1.01 diluted EPS) from $380.3 million ($0.69 diluted EPS) in 2024, building on the Q4 2025 earnings reported on January 29, 2026.
-
Strengthened Capital & Liquidity
All regulatory capital ratios exceeded 'well capitalized' minimums, with CET1 at 10.99% and Tier 1 leverage at 9.63%. Liquid assets increased to $6.1 billion, and the loans to deposits ratio improved to 96.1%.
-
Strategic De-risking of Loan Portfolio
Commercial real estate loan concentration ratio reduced to 333% from 362% in 2024, with a target of 300% by 2027. Net loan charge-offs decreased to $116.9 million in 2025.
-
New Share Repurchase Program Authorized
The Board authorized a new program on February 24, 2026, for up to 25 million shares, effective April 27, 2026. The company repurchased 6.1 million shares in 2025 under a previous plan.
Analysis
The 2025 annual report details a robust financial performance, with net income significantly increasing to $598.0 million and diluted EPS to $1.01. The company strengthened its balance sheet by improving key capital and liquidity ratios, maintaining them well above regulatory minimums. A strategic reduction in commercial real estate loan concentration is underway, aiming for further de-risking. While non-performing assets saw an increase, they remain well-covered by the allowance for loan losses. The Board's authorization of a new 25 million share repurchase program signals confidence in future value creation. The company also projects continued net interest income and margin growth for 2026.
At the time of this filing, VLY was trading at $12.61 on NASDAQ in the Finance sector, with a market capitalization of approximately $7B. The 52-week trading range was $7.48 to $13.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.